Sovran Advisors »

Galectin Therapeutics shares owned by Sovran Advisors

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Sovran Advisors from 13F filings

Historical chart of Sovran Advisors investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Sovran Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Sovran Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $214k 186k 1.15